5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Author： Wagner-Johnston Nina D.   Sloan Jeff A.   Liu Heshan   Kearns Ann E.   Hines Stephanie L.   Puttabasavaiah Suneetha   Dakhil Shaker R.   Lafky Jacqueline M.   Perez Edith A.   Loprinzi Charles L.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|15|2537-2543

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.15, 2015-08, pp. : 2537-2543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial

By Stagl Jamie M.   Bouchard Laura C.   Lechner Suzanne C.   Blomberg Bonnie B.   Gudenkauf Lisa M.   Jutagir Devika R.   Glück Stefan   Derhagopian Robert P.   Carver Charles S.   Antoni Michael H.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1873-1881

Blackwell Publishing

Access to resources Recommend Favorite

A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients

By Karnon J.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 513-525

Adis International

Access to resources Recommend Favorite

Letrozole after tamoxifen decreases BMD in breast cancer

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Letrozole effective after tamoxifen in breast cancer

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Prevention of Osteoporosis: Four-Year Follow-Up of a Cohort of Postmenopausal Women Treated with an Ossein-Hydroxyapatite Compound

By Fernández-Pareja Antonio  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 227-232

Adis International

Access to resources Recommend Favorite